Literature DB >> 35468320

Tirzepatide adds hepatoprotection to its armoury.

Giovanni Targher1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35468320     DOI: 10.1016/S2213-8587(22)00074-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  1 in total

Review 1.  Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review.

Authors:  Vivek P Chavda; Jinal Ajabiya; Divya Teli; Joanna Bojarska; Vasso Apostolopoulos
Journal:  Molecules       Date:  2022-07-05       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.